ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000185437 | SH3BGR | SH3 domain binding glutamate rich protein | [
"P55822"
] | 21 | 39445855-39515506 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"CAB003685"
] | [
"21-GARP"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 1 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 28: Astrocytes - Homeostasis & neuron support | Cluster 30: Skeletal muscle - Striated muscle contraction | Group enriched | Detected in all | 6 | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 15,264 | 8 |
ENSG00000185442 | FAM174B | Family with sequence similarity 174 member B | [
"Q3ZCQ3"
] | 15 | 92617448-92809884 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA015306"
] | [
"LOC400451",
"MGC102891"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Intermediate filaments"
] | [] | [] | [] | Approved | Approved | null | null | No | No | Cluster 13: Non-specific - Mitochondria | Cluster 24: Neurons - Mixed function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 60: Stomach - Digestion | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 15,265 | 9 |
ENSG00000185448 | FAM47A | Family with sequence similarity 47 member A | [
"Q5JRC9"
] | X | 34129752-34132314 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA000610"
] | [
"MGC27003"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 1 | null | null | null | Cluster 53: Neurons - Mixed function | null | Cluster 77: Late primary spermatocytes - Spermiogenesis: Golgi Phase | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in single | 28 | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in some | 49 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,266 | 7 |
ENSG00000185453 | ZSWIM9 | Zinc finger SWIM-type containing 9 | [
"Q86XI8"
] | 19 | 48170680-48197620 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA061028"
] | [
"C19orf68",
"LOC374920"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | 4 | null | null | null | Cluster 32: Cerebral cortex - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 78: Brain - Neuronal signaling | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 15,267 | 7 |
ENSG00000185467 | KPNA7 | Karyopherin subunit alpha 7 | [
"A9QM74"
] | 7 | 99173572-99250075 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA031395"
] | [
"IPOA8"
] | [
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 1 | null | null | null | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 41: Oocytes - Oogenesis | Cluster 75: Ovary - Mixed function | Group enriched | Detected in some | 5 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Cell type enriched | Detected in some | 37 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 15,268 | 7 |
ENSG00000185475 | TMEM179B | Transmembrane protein 179B | [
"Q7Z7N9"
] | 11 | 62787402-62790400 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016585",
"HPA062068"
] | [] | [
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Enhanced | null | null | 49 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 8: Immune cells - Immune response | Cluster 24: Non-specific - Unknown function | Cluster 8: Non-specific - Secretory pathway | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 15,269 | 2 |
ENSG00000185477 | GPRIN3 | GPRIN family member 3 | [
"Q6ZVF9"
] | 4 | 89236383-89307800 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA043148",
"HPA057666",
"HPA059092"
] | [
"FLJ42625",
"GRIN3"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoli"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | 2 | No | null | Cluster 33: Non-specific - ATP binding | Cluster 25: Non-specific - Transcription | Cluster 51: Myeloma - Immunoglobulins | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 61: Non-specific - Transcription | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in many | 7 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,270 | 7 |
ENSG00000185479 | KRT6B | Keratin 6B | [
"P04259"
] | 12 | 52446651-52452146 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000130",
"HPA045697",
"HPA061168"
] | [
"KRTL1"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant",
"Ectodermal dysplasia",
"Palmoplantar keratoderma"
] | [
"Intermediate filaments"
] | [] | [] | [] | Approved | Supported | null | 30 | null | null | null | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in many | 5 | Group enriched | Detected in many | 6 | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 15,271 | 3 |
ENSG00000185480 | PARPBP | PARP1 binding protein | [
"Q9NWS1"
] | 12 | 102120183-102197520 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039677"
] | [
"C12orf48",
"FLJ20641",
"PARI"
] | [
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 2 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 38: Non-specific - Transcription | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 5 | 2 | 4 | [
"Lung Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Lung Squamous Cell Carcinoma"
] | 15,272 | 9 |
ENSG00000185482 | STAC3 | SH3 and cysteine rich domain 3 | [
"Q96MF2"
] | 12 | 57243453-57251188 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039285",
"HPA039527"
] | [
"MGC2793"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Enhanced | null | null | 34 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 48: Non-specific - Mixed function | Cluster 33: Sarcoma - Muscle contraction | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 19: Skeletal muscle - Striated muscle contraction | Group enriched | Detected in many | 38 | Cancer enriched | Detected in many | 7 | Cancer enhanced | Detected in all | null | Group enriched | Detected in many | 5 | Immune cell enhanced | Detected in some | null | 2 | 0 | 2 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 15,273 | 1 |
ENSG00000185483 | ROR1 | Receptor tyrosine kinase like orphan receptor 1 | [
"Q01973"
] | 1 | 63774017-64181498 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"NTRKR1"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Wnt signaling pathway"
] | [
"Kinase",
"Receptor",
"Transferase"
] | [
"Deafness",
"Disease variant",
"Non-syndromic deafness"
] | [] | [] | [
"Intracellular and membrane"
] | [
"Receptor"
] | null | null | null | 11 | null | null | null | Cluster 15: Non-specific - Transcription | Cluster 64: Connective tissue cells - ECM organization | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 69: Parathyroid gland - Mixed function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,274 | 8 |
ENSG00000185499 | MUC1 | Mucin 1, cell surface associated | [
"P15941"
] | 1 | 155185824-155192916 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000036",
"CAB001986",
"HPA004179",
"HPA007235",
"HPA008855",
"CAB080102",
"CAB080103"
] | [
"ADMCKD",
"ADMCKD1",
"Ca15-3",
"CD227",
"EMA",
"KL-6",
"MCD",
"MCKD",
"MCKD1",
"PEM",
"PUM"
] | [
"Cancer-related genes",
"CD markers",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [] | [] | [
"Cancer-related genes",
"Tumor suppressor"
] | [
"Plasma membrane"
] | [] | [
"Secreted in other tissues"
] | [
"No annotated function"
] | Supported | Enhanced | null | 29 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 44: Non-specific - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 68: Foveolar cells - Mucosal defense | Cluster 60: Stomach - Digestion | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 3 | 0 | 3 | [
"Kidney Chromophobe"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 15,275 | 6 |
ENSG00000185504 | FAAP100 | FA core complex associated protein 100 | [
"Q0VG06"
] | 17 | 81539885-81553961 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA023954",
"HPA024626",
"HPA026532"
] | [
"C17orf70",
"FLJ22175"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 31 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 15: Non-specific - Transcription | Cluster 27: Breast cancer - Unknown function | Cluster 54: Intestinal epithelial cells - Intestinal epi homeostasis & respiration | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,276 | 4 |
ENSG00000185507 | IRF7 | Interferon regulatory factor 7 | [
"Q92985"
] | 11 | 612553-615983 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017694",
"HPA052757"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Antiviral defense",
"Host-virus interaction",
"Immunity",
"Innate immunity",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 40 | No | null | Cluster 44: Plasmacytoid DCs - Plasma membrane proteins | Cluster 8: Immune cells - Immune response | Cluster 55: Lymphoma - Immune response | Cluster 6: Plasmacytoid dendritic cells - Viral sensing & interferon response | Cluster 70: Non-specific - Protein processing | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in many | 14 | Immune cell enriched | Detected in all | 12 | 1 | 0 | 1 | [] | [
"Rectum Adenocarcinoma"
] | [
"Rectum Adenocarcinoma"
] | 15,277 | 9 |
ENSG00000185513 | L3MBTL1 | L3MBTL histone methyl-lysine binding protein 1 | [
"Q9Y468"
] | 20 | 43489442-43550954 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA059648"
] | [
"dJ138B7.3",
"DKFZp586P1522",
"KIAA0681",
"L3MBTL",
"ZC2HC3"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [
"Nuclear bodies",
"Midbody ring"
] | [] | [] | Supported | null | null | 40 | Yes | null | null | Cluster 1: Neurons - Mixed function | Cluster 56: Non-specific - Sensory perception | Cluster 102: Non-specific - Mixed function | Cluster 64: Non-specific - Transcription | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 15,278 | 5 |
ENSG00000185515 | BRCC3 | BRCA1/BRCA2-containing complex subunit 3 | [
"P46736"
] | X | 155071420-155123077 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048737"
] | [
"BRCC36",
"C6.1A",
"CXorf53"
] | [
"Disease related genes",
"Enzymes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"DNA damage",
"DNA repair",
"Mitosis",
"Ubl conjugation pathway"
] | [
"Chromatin regulator",
"Hydrolase",
"Metalloprotease",
"Protease"
] | [
"Proto-oncogene"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | null | null | 28 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 36: Non-specific - mRNA processing | Cluster 7: Non-specific - Transcription | Cluster 17: Intestine - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Rectum Adenocarcinoma"
] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | 15,279 | 2 |
ENSG00000185518 | SV2B | Synaptic vesicle glycoprotein 2B | [
"Q7L1I2"
] | 15 | 91099950-91302565 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046247"
] | [
"HsT19680",
"KIAA0735"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Neurotransmitter transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 3 | null | null | null | Cluster 14: Neurons - Synaptic function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 46: Brain & retina - Neuronal signaling | Group enriched | Detected in some | 23 | Cancer enhanced | Detected in some | null | Not detected | Not detected | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,280 | 5 |
ENSG00000185519 | FAM131C | Family with sequence similarity 131 member C | [
"Q96AQ9"
] | 1 | 16057769-16073651 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA031046"
] | [
"C1orf117",
"FLJ36766"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Intermediate filaments",
"Cytosol"
] | [
"Nucleoli"
] | [] | [] | Approved | Uncertain | null | 5 | null | null | null | Cluster 25: Non-specific - Transcription | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 50: Renal epithelial cells - Ion transport and pH regulation | Cluster 27: Cerebellum - Synaptic function | Group enriched | Detected in many | 5 | Low cancer specificity | Detected in many | null | Group enriched | Detected in many | 4 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 15,281 | 6 |
ENSG00000185522 | LMNTD2 | Lamin tail domain containing 2 | [
"Q8IXW0"
] | 11 | 554850-560738 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA058474",
"HPA073912"
] | [
"C11orf35",
"MGC35138"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytoplasmic bodies"
] | [] | [] | [] | Approved | Uncertain | null | 17 | null | null | null | Cluster 15: Non-specific - Transcription | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 21: Testis - Mixed function | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in many | 7 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Rectum Adenocarcinoma"
] | [
"Rectum Adenocarcinoma"
] | 15,282 | 4 |
ENSG00000185523 | SPATA45 | Spermatogenesis associated 45 | [
"Q537H7"
] | 1 | 212830141-212847649 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [
"HPA049921"
] | [
"C1orf227",
"LOC149643"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nuclear speckles",
"Cytosol"
] | [] | [] | [] | Uncertain | Uncertain | null | null | null | null | null | Cluster 26: Oligodendrocytes - Mixed function | Cluster 3: Rhabdoid - Membrane components | Cluster 90: Elongating spermatids - Spermiogenesis: Elongation | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in some | 4 | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in some | 6 | Immune cell enhanced | Detected in some | null | 0 | 0 | 0 | [] | [] | [] | 15,283 | 5 |
ENSG00000185527 | PDE6G | Phosphodiesterase 6G | [
"P18545"
] | 17 | 81650459-81663112 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045118"
] | [
"PDEG",
"RP57"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Sensory transduction",
"Vision"
] | [
"Hydrolase"
] | [
"Retinitis pigmentosa"
] | [
"Vesicles"
] | [] | [] | [] | Uncertain | Supported | null | 5 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 50: Non-specific - Nucleic acid binding | Cluster 47: Leukemia - Hemostasis | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 42: Retina - Visual perception | Tissue enriched | Detected in many | 98 | Group enriched | Detected in some | 5 | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in some | 30 | Group enriched | Detected in many | 6 | 1 | 0 | 1 | [
"Skin Cutaneous Melanoma"
] | [] | [
"Skin Cutaneous Melanoma"
] | 15,284 | 4 |
ENSG00000185532 | PRKG1 | Protein kinase cGMP-dependent 1 | [
"Q13976"
] | 10 | 50990888-52298423 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA007699",
"CAB009629"
] | [
"PGK",
"PKG",
"PKG1",
"PRKG1B",
"PRKGR1B"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Allosteric enzyme",
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Aortic aneurysm",
"Disease variant"
] | [
"Vesicles",
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 11 | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 64: Connective tissue cells - ECM organization | Cluster 110: Mural cells - ECM organization | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 38 | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,285 | 7 |
ENSG00000185551 | NR2F2 | Nuclear receptor subfamily 2 group F member 2 | [
"P24468"
] | 15 | 96325938-96340263 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA058974"
] | [
"ARP1",
"COUP-TFII",
"COUPTF2",
"COUPTFB",
"NF-E3",
"SVP40",
"TFCOUP2"
] | [
"Disease related genes",
"Human disease related genes",
"Nuclear receptors",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Receptor"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | null | null | 14 | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 110: Mural cells - ECM organization | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 15,286 | 4 |
ENSG00000185559 | DLK1 | Delta like non-canonical Notch ligand 1 | [
"P80370"
] | 14 | 100725705-100738224 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB005872",
"HPA062262"
] | [
"Delta1",
"FA1",
"pG2",
"Pref-1",
"ZOG"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Approved | Enhanced | null | 12 | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 65: Non-specific - Unknown function | Cluster 108: Fibroblasts - ECM organization | Cluster 43: Placenta - Pregnancy hormone signaling | Group enriched | Detected in many | 4 | Group enriched | Detected in many | 5 | Cancer enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,287 | 2 |
ENSG00000185561 | TLCD2 | TLC domain containing 2 | [
"A6NGC4"
] | 17 | 1702816-1710377 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [
"HPA046063"
] | [] | [
"Predicted membrane proteins"
] | [] | [] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 20: Non-specific - DNA binding | Cluster 6: Non-specific - Immune response | Cluster 72: Neuronal - Signal transduction | Cluster 105: Non-specific - Mixed function | Cluster 28: Liver & Adrenal gland - Secretion | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 5 | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,288 | 5 |
ENSG00000185565 | LSAMP | Limbic system associated membrane protein | [
"Q13449"
] | 3 | 115802363-117139389 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA054051",
"HPA076122"
] | [
"IGLON3",
"LAMP"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Enhanced | null | null | 12 | null | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 28: Astrocytes - Homeostasis & neuron support | Cluster 73: Brain - Neuronal signaling | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 15,289 | 3 |
ENSG00000185567 | AHNAK2 | AHNAK nucleoprotein 2 | [
"Q8IVF2"
] | 14 | 104937244-104978374 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000878",
"HPA002940",
"HPA004145",
"HPA020111"
] | [
"C14orf78"
] | [
"Cancer-related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Cancer-related genes"
] | [
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Enhanced | Enhanced | null | 3 | No | No | null | Cluster 45: Non-specific - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 58: Skin - Keratinization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [] | [
"Glioblastoma Multiforme",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 15,290 | 5 |
ENSG00000185585 | OLFML2A | Olfactomedin like 2A | [
"Q68BL7"
] | 9 | 124777133-124814885 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA021180",
"HPA022254"
] | [
"FLJ00237"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Vesicles"
] | [
"Golgi apparatus"
] | [
"Secreted - unknown location"
] | [
"No annotated function"
] | Approved | Approved | null | null | null | null | null | Cluster 42: Choroid plexus - Mitochondria | Cluster 69: Skin cancer - ECM organization | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 5: Spleen - Immune response | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Lung Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 15,291 | 1 |
ENSG00000185591 | SP1 | Sp1 transcription factor | [
"P08047"
] | 12 | 53380176-53416446 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000330",
"HPA001853",
"HPA012292"
] | [] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Biological rhythms",
"Host-virus interaction",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Repressor"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Supported | null | 157 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 25: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,292 | 7 |
ENSG00000185608 | MRPL40 | Mitochondrial ribosomal protein L40 | [
"Q9NQ50"
] | 22 | 19432545-19436075 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006181"
] | [
"MRP-L22",
"NLVCF"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Mitochondria"
] | [
"Nucleoli"
] | [] | [] | Supported | Uncertain | null | 61 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 21: Non-specific - Metabolism | Cluster 66: Non-specific - Mitochondria | Cluster 97: Non-specific - Cellular respiration | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Prostate Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Prostate Adenocarcinoma"
] | 15,293 | 3 |
ENSG00000185610 | DBX2 | Developing brain homeobox 2 | [
"Q6ZNG2"
] | 12 | 45014672-45051099 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA065045",
"HPA066053"
] | [
"FLJ16139"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [] | [
"DNA-binding"
] | [] | [
"Nucleoplasm",
"Nuclear membrane"
] | [
"Vesicles"
] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 28: Astrocytes - Homeostasis & neuron support | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in single | 6 | Not detected | Not detected | null | Cancer enriched | Detected in single | 32 | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 15,294 | 4 |
ENSG00000185614 | INKA1 | Inka box actin regulator 1 | [] | 3 | 49803261-49805030 | Evidence at transcript level | Evidence at transcript level | null | null | [
"HPA041879"
] | [
"C3orf54",
"FAM212A"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | [] | Approved | Uncertain | null | 1 | null | null | Cluster 32: Basophils - Transcription | Cluster 20: Macrophages & Microglia - Immune response | Cluster 35: RS4;11 - Unknown function | Cluster 47: Platelets - Hemostasis | Cluster 58: Skin - Keratinization | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 4 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 5 | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 15,295 | 6 |
ENSG00000185615 | PDIA2 | Protein disulfide isomerase family A member 2 | [
"Q13087"
] | 16 | 283164-287215 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA051692",
"HPA053492"
] | [
"PDA2",
"PDI",
"PDIP",
"PDIR"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Chaperone",
"Isomerase"
] | [] | [] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | null | Enhanced | null | 6 | null | null | null | Cluster 30: White matter - Myelination | Cluster 51: Myeloma - Immunoglobulins | Cluster 5: Pancreatic acinar cells - Pancreatic exocrine secretion | Cluster 8: Pancreas - Proteolysis | Tissue enriched | Detected in many | 12 | Cancer enhanced | Detected in many | null | Cancer enriched | Detected in many | 4 | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,296 | 8 |
ENSG00000185619 | PCGF3 | Polycomb group ring finger 3 | [
"Q3KNV8"
] | 4 | 705748-770089 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA061879"
] | [
"DONG1",
"FLJ36550",
"MGC40413",
"RNF3",
"RNF3A"
] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Repressor"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 43 | null | null | Cluster 32: Basophils - Transcription | Cluster 15: Non-specific - Transcription | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 15,297 | 5 |
ENSG00000185621 | LMLN | Leishmanolysin like peptidase | [
"Q96KR4"
] | 3 | 197960200-198043720 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA016481",
"HPA028844"
] | [
"Gp63",
"LMNL1",
"Msp"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis"
] | [
"Hydrolase",
"Metalloprotease",
"Protease"
] | [] | [
"Cytosol"
] | [
"Focal adhesion sites"
] | [] | [] | Supported | Uncertain | null | null | null | null | Cluster 30: Non-specific - DNA binding | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,298 | 7 |
ENSG00000185624 | P4HB | Prolyl 4-hydroxylase subunit beta | [
"P07237"
] | 17 | 81843159-81860856 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB012463",
"HPA018884"
] | [
"DSI",
"ERBA2L",
"GIT",
"P4Hbeta",
"PDI",
"PDIA1",
"PO4DB",
"PO4HB",
"PROHB"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Chaperone",
"Isomerase"
] | [
"Craniosynostosis",
"Disease variant",
"Osteogenesis imperfecta"
] | [
"Endoplasmic reticulum"
] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | Supported | Enhanced | null | 103 | No | No | Cluster 10: Non-specific - Membrane trafficking | Cluster 12: Non-specific - Vasculature | Cluster 63: Non-specific - Protein processing | Cluster 8: Non-specific - Secretory pathway | Cluster 8: Pancreas - Proteolysis | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 15,299 | 5 |
ENSG00000185627 | PSMD13 | Proteasome 26S subunit, non-ATPase 13 | [
"Q9UNM6"
] | 11 | 236966-252984 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA038691",
"HPA038692"
] | [
"p40.5",
"Rpn9"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nuclear speckles"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 145 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 27: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 15,300 | 3 |
ENSG00000185630 | PBX1 | PBX homeobox 1 | [
"P40424"
] | 1 | 164555584-164899296 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003505",
"HPA003881",
"CAB018768"
] | [] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Sexual differentiation",
"Steroidogenesis",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding",
"Repressor"
] | [
"Cancer-related genes",
"Disease variant",
"Proto-oncogene"
] | [
"Nucleoplasm"
] | [
"Nuclear bodies",
"Cytosol"
] | [] | [] | Supported | Supported | null | 30 | null | null | Cluster 41: Basophils - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 27: Breast cancer - Unknown function | Cluster 105: Non-specific - Mixed function | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 15,301 | 1 |
ENSG00000185634 | SHC4 | SHC adaptor protein 4 | [
"Q6S5L8"
] | 15 | 48823741-48963919 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA074146"
] | [
"RaLP",
"SHCD"
] | [
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | null | null | 6 | null | null | null | Cluster 11: White matter - Signal transduction | Cluster 54: Non-specific - Transcription | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,303 | 3 |
ENSG00000185640 | KRT79 | Keratin 79 | [
"Q5XKE5"
] | 12 | 52821408-52834311 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA059347"
] | [
"K6L",
"KRT6L"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 27 | null | null | null | null | Cluster 49: HMC-1 - Innate immune response | Cluster 49: Apical squamous epithelium - Epithelial barrier & keratinization | Cluster 9: Skin - Hair follicle development | Tissue enriched | Detected in some | 21 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,304 | 1 |
ENSG00000185650 | ZFP36L1 | ZFP36 ring finger protein like 1 | [
"Q07352"
] | 14 | 68787660-68796253 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA001301"
] | [
"Berg36",
"BRF1",
"cMG1",
"ERF1",
"RNF162B",
"TIS11B"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA transport",
"Transport"
] | [
"Developmental protein",
"DNA-binding",
"Ribonucleoprotein",
"RNA-binding"
] | [
"Cancer-related genes"
] | [] | [] | [] | [] | null | Uncertain | null | 12 | null | null | Cluster 20: Non-specific - DNA binding | Cluster 39: Astrocytes - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 100: Stratified epithelial cells - Barrier functions | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in all | 6 | 1 | 0 | 1 | [] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | 15,305 | 6 |
ENSG00000185651 | UBE2L3 | Ubiquitin conjugating enzyme E2 L3 | [
"P68036"
] | 22 | 21549447-21624034 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045609",
"HPA062415"
] | [
"UBCH7"
] | [
"Enzymes",
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation",
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [
"Primary cilium transition zone"
] | [] | [] | Approved | Approved | null | 81 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 66: Non-specific - Mitochondria | Cluster 97: Non-specific - Cellular respiration | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 15,306 | 9 |
ENSG00000185652 | NTF3 | Neurotrophin 3 | [
"P20783"
] | 12 | 5432108-5521536 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA032001"
] | [
"NGF2"
] | [
"Cancer-related genes",
"Predicted secreted proteins",
"RAS pathway related proteins"
] | [] | [
"Growth factor"
] | [
"Cancer-related genes"
] | [
"Vesicles"
] | [] | [
"Secreted in other tissues"
] | [
"Growth factor"
] | Approved | Uncertain | null | 11 | null | null | null | Cluster 35: Non-specific - DNA binding | Cluster 64: Connective tissue cells - ECM organization | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,307 | 8 |
ENSG00000185658 | BRWD1 | Bromodomain and WD repeat domain containing 1 | [
"Q9NSI6"
] | 21 | 39184176-39321559 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027343",
"HPA030943",
"HPA030944",
"HPA030945",
"CAB034184"
] | [
"C21orf107",
"DCAF19",
"FLJ11315",
"N143",
"WDR9"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator"
] | [
"Ciliopathy",
"Primary ciliary dyskinesia"
] | [
"Nucleoplasm",
"Cytosol"
] | [
"Nucleoli",
"Vesicles",
"Plasma membrane",
"Mitotic spindle"
] | [] | [] | Approved | Approved | null | 8 | Yes | null | Cluster 3: Non-specific - Nuclear processes | Cluster 31: Non-specific - Transcription | Cluster 47: Leukemia - Hemostasis | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 73: Brain - Neuronal signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 15,308 | 5 |
ENSG00000185662 | SMIM23 | Small integral membrane protein 23 | [
"A6NLE4"
] | 5 | 171782432-171796126 | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | [] | [
"C5orf50",
"LOC644994"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | null | Cluster 72: Neuronal - Signal transduction | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 23: Testis - Spermatogenesis | Tissue enriched | Detected in single | 197 | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,309 | 9 |
ENSG00000185668 | POU3F1 | POU class 3 homeobox 1 | [
"Q03052"
] | 1 | 38043829-38046793 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA055980",
"HPA073824"
] | [
"OCT6",
"OTF6",
"SCIP"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | null | null | null | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 20: Non-specific - Transcription regulation | Cluster 37: Skin - Keratinization | Group enriched | Detected in some | 5 | Cancer enriched | Detected in some | 5 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,312 | 6 |
ENSG00000185669 | SNAI3 | Snail family transcriptional repressor 3 | [
"Q3KNW1"
] | 16 | 88677688-88686507 | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | [
"HPA071127"
] | [
"SMUC",
"Zfp293",
"ZNF293"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | null | null | null | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 32: Cerebral cortex - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 30: Skeletal muscle - Striated muscle contraction | Tissue enriched | Detected in many | 4 | Low cancer specificity | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Adenocarcinoma"
] | 15,313 | 2 |
ENSG00000185670 | ZBTB3 | Zinc finger and BTB domain containing 3 | [
"Q9H5J0"
] | 11 | 62748319-62754184 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035321",
"HPA035322"
] | [
"FLJ23392"
] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 9 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 11: White matter - Signal transduction | Cluster 24: Non-specific - Unknown function | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 40: Non-specific - Mixed function | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Papillary Cell Carcinoma",
"Stomach Adenocarcinoma"
] | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Stomach Adenocarcinoma"
] | 15,314 | 4 |
ENSG00000185674 | LYG2 | Lysozyme g2 | [
"Q86SG7"
] | 2 | 99242246-99255666 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA039179"
] | [
"LYGA2",
"LYGH"
] | [
"Predicted secreted proteins"
] | [] | [
"Glycosidase",
"Hydrolase"
] | [] | [] | [] | [
"Secreted in other tissues"
] | [
"Enzyme"
] | null | Uncertain | null | 12 | null | null | Cluster 24: Non-specific - Transcription | Cluster 2: Neurons - Nucleosome | Cluster 51: Myeloma - Immunoglobulins | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 37: Skin - Keratinization | Group enriched | Detected in some | 4 | Low cancer specificity | Detected in some | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 15,315 | 8 |
ENSG00000185681 | MORN5 | MORN repeat containing 5 | [
"Q5VZ52"
] | 9 | 122159908-122200088 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"C9orf113",
"C9orf18",
"FLJ46909"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | 8 | null | null | null | Cluster 3: Choroid plexus - Cilium | Cluster 10: Ciliated cells - Ion channel activity | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in many | null | Group enriched | Detected in many | 6 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Prostate Adenocarcinoma"
] | [] | [
"Prostate Adenocarcinoma"
] | 15,316 | 9 |
ENSG00000185686 | PRAME | PRAME nuclear receptor transcriptional regulator | [
"P78395"
] | 22 | 22547701-22559361 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045153",
"HPA068562",
"CAB080138"
] | [
"CT130",
"MAPE"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Differentiation",
"Growth regulation",
"Transcription",
"Transcription regulation",
"Ubl conjugation pathway"
] | [
"Repressor"
] | [] | [
"Nucleoplasm"
] | [
"Plasma membrane"
] | [] | [] | Approved | Enhanced | null | 27 | null | null | null | null | Cluster 5: Rhabdoid - Unknown function | Cluster 106: Spermatogonia - Spermatogonial differentiation | Cluster 79: Testis - Spermatogenesis | Tissue enriched | Detected in some | 11 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,317 | 2 |
ENSG00000185697 | MYBL1 | MYB proto-oncogene like 1 | [
"P10243"
] | 8 | 66562175-66614247 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008791"
] | [
"A-myb",
"AMYB"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Spermatogenesis",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Uncertain | null | 8 | null | null | Cluster 15: NK-cells - Unknown function | Cluster 49: Hindbrain - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 15,318 | 8 |
ENSG00000185716 | MOSMO | Modulator of smoothened | [
"Q8NHV5"
] | 16 | 22007638-22087534 | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | [] | [
"ATTHOG",
"BC030336",
"C16orf52"
] | [
"Predicted membrane proteins"
] | [
"Differentiation"
] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 53: Neurons - Mixed function | Cluster 69: Skin cancer - ECM organization | Cluster 102: Non-specific - Mixed function | Cluster 69: Parathyroid gland - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in single | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 15,319 | 9 |
ENSG00000185721 | DRG1 | Developmentally regulated GTP binding protein 1 | [
"Q9Y295"
] | 22 | 31399604-31530634 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001218"
] | [
"NEDD3"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Host-virus interaction"
] | [
"Hydrolase"
] | [
"Disease variant",
"Dwarfism",
"Intellectual disability"
] | [
"Nucleoplasm",
"Nuclear bodies"
] | [
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 241 | No | No | Cluster 5: Non-specific - Cell proliferation | Cluster 55: Non-specific - Transcription | Cluster 66: Non-specific - Mitochondria | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 39: Testis - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in all | 4 | Low immune cell specificity | Detected in all | null | 3 | 4 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 15,320 | 2 |
ENSG00000185722 | ANKFY1 | Ankyrin repeat and FYVE domain containing 1 | [
"Q9P2R3"
] | 17 | 4163821-4263995 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024513",
"HPA024522",
"HPA065849"
] | [
"ANKHZN",
"BTBD23",
"KIAA1255",
"RANK-5",
"ZFYVE14"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Endocytosis"
] | [] | [] | [
"Endosomes"
] | [] | [] | [] | Enhanced | Approved | null | 22 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 39: Astrocytes - Mixed function | Cluster 42: Non-specific - Unknown function | Cluster 7: Non-specific - Transcription | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,321 | 6 |
ENSG00000185728 | YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 | [
"Q7Z739"
] | 8 | 63168553-63212786 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"FLJ31657"
] | [
"Predicted intracellular proteins"
] | [
"Host-virus interaction"
] | [
"RNA-binding"
] | [] | [] | [] | [] | [] | null | null | null | 33 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 31: Non-specific - Transcription | Cluster 40: Non-specific - Unknown function | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,322 | 2 |
ENSG00000185730 | ZNF696 | Zinc finger protein 696 | [
"Q9H7X3"
] | 8 | 143289676-143299952 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA057855",
"HPA072473"
] | [
"FLJ14129"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [] | [] | Approved | Uncertain | null | 38 | No | No | Cluster 30: Non-specific - DNA binding | Cluster 48: Non-specific - Mixed function | Cluster 40: Non-specific - Unknown function | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | 15,323 | 7 |
ENSG00000185737 | NRG3 | Neuregulin 3 | [
"P56975"
] | 10 | 81875194-82987179 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA075789"
] | [] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [] | [
"Growth factor"
] | [
"Cancer-related genes"
] | [
"Vesicles"
] | [] | [
"Secreted in brain"
] | [
"Growth factor"
] | Uncertain | null | null | null | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 6: Leukemia - Signal transduction | Cluster 28: Astrocytes - Homeostasis & neuron support | Cluster 73: Brain - Neuronal signaling | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 15,325 | 7 |
ENSG00000185739 | SRL | Sarcalumenin | [
"Q86TD4"
] | 16 | 4189374-4242080 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041535",
"HPA045520"
] | [
"SAR"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [
"Intracellular and membrane"
] | [
"No annotated function"
] | null | Enhanced | null | null | null | null | null | Cluster 44: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 62: Skeletal muscle - Muscle contraction | Group enriched | Detected in many | 24 | Group enriched | Detected in some | 9 | Cancer enhanced | Detected in some | null | Cell type enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,326 | 9 |
ENSG00000185742 | C11orf87 | Chromosome 11 open reading frame 87 | [
"Q6NUJ2"
] | 11 | 109422190-109429167 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA034656"
] | [
"LOC399947",
"LOH11CR1A",
"NEURIM1"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Approved | null | 19 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 5: Rhabdoid - Unknown function | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 73: Brain - Neuronal signaling | Tissue enriched | Detected in some | 10 | Cancer enriched | Detected in single | 23 | Cancer enhanced | Detected in single | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,327 | 1 |
ENSG00000185745 | IFIT1 | Interferon induced protein with tetratricopeptide repeats 1 | [
"P09914"
] | 10 | 89392546-89406487 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB045980",
"HPA053890",
"HPA055380",
"CAB080338"
] | [
"G10P1",
"GARG-16",
"IFI56",
"IFNAI1"
] | [
"Predicted intracellular proteins"
] | [
"Antiviral defense",
"Host-virus interaction",
"Immunity",
"Innate immunity"
] | [
"RNA-binding"
] | [] | [
"Cytosol"
] | [] | [] | [] | Enhanced | Supported | null | 10 | null | null | Cluster 28: Neutrophils - Unknown function | Cluster 43: Hindbrain - Mixed function | Cluster 31: Non-specific - Antiviral immune response | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 15,328 | 2 |
ENSG00000185753 | CXorf38 | Chromosome X open reading frame 38 | [
"Q8TB03"
] | X | 40626921-40647561 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA050120"
] | [
"MGC39350"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [] | [] | [] | [
"Vesicles",
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 11 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 13: Oligodendrocytes - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 15,329 | 9 |
ENSG00000185758 | CLDN24 | Claudin 24 | [
"A6NM45"
] | 4 | 183321764-183322426 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"CLDN21"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | Cluster 32: Cerebral cortex - Mixed function | Cluster 71: Lymphoma - Inflammatory response | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | null | Not detected | Not detected | null | Cancer enriched | Detected in single | 6 | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,330 | 9 |
ENSG00000185760 | KCNQ5 | Potassium voltage-gated channel subfamily Q member 5 | [
"Q9NR82"
] | 6 | 72621792-73198853 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA016655"
] | [
"Kv7.5"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Voltage-gated ion channels"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Voltage-gated channel"
] | [
"Disease variant",
"Intellectual disability"
] | [
"Cytoplasmic bodies"
] | [] | [] | [] | Uncertain | Approved | null | null | null | null | null | Cluster 24: Neurons - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 25: Non-specific - Basic cellular processes | Group enriched | Detected in some | 4 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 15,331 | 3 |
ENSG00000185761 | ADAMTSL5 | ADAMTS like 5 | [] | 19 | 1505022-1513604 | Evidence at protein level | Evidence at protein level | null | null | [
"HPA044050"
] | [
"THSD6"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Golgi apparatus"
] | [] | [
"Secreted to extracellular matrix"
] | [] | Approved | null | null | null | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 23: Choroid plexus - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 63: Non-specific - Basic cellular processes | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 0 | 0 | 0 | [] | [] | [] | 15,332 | 4 |
ENSG00000185774 | KCNIP4 | Potassium voltage-gated channel interacting protein 4 | [
"Q6PIL6"
] | 4 | 20728606-21948772 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA022862",
"HPA066717"
] | [
"CALP",
"KCHIP4",
"MGC44947"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Voltage-gated channel"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | null | Supported | 12 | null | null | null | Cluster 14: Neurons - Synaptic function | Cluster 24: Non-specific - Unknown function | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 10: Brain - Synaptic signal transduction | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,333 | 9 |
ENSG00000185775 | SPATA31A6 | SPATA31 subfamily A member 6 | [
"Q5VVP1"
] | 9 | 42183659-42189887 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [
"HPA051472"
] | [
"FAM75A6"
] | [
"Essential proteins",
"Predicted membrane proteins"
] | [
"Differentiation",
"Spermatogenesis"
] | [] | [] | [
"Acrosome",
"Equatorial segment"
] | [] | [] | [] | Approved | null | null | null | null | null | null | null | Cluster 66: Non-specific - Mitochondria | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 23: Testis - Spermatogenesis | Tissue enriched | Detected in single | 19 | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,334 | 4 |
ENSG00000185792 | NLRP9 | NLR family pyrin domain containing 9 | [
"Q7RTR0"
] | 19 | 55708438-55738402 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA042623"
] | [
"CLR19.1",
"NALP9",
"NOD6",
"PAN12"
] | [
"Predicted intracellular proteins"
] | [
"Immunity",
"Inflammatory response",
"Innate immunity"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | null | null | null | null | null | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in single | null | Not detected | Not detected | null | Cancer enriched | Detected in single | 40 | Group enriched | Detected in some | 11 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,336 | 5 |
ENSG00000185798 | WDR53 | WD repeat domain 53 | [
"Q7Z5U6"
] | 3 | 196554177-196568674 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA016420"
] | [
"MGC12928",
"MGC64882"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 3 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 28: Oligodendrocytes - Mixed function | Cluster 63: Non-specific - Protein processing | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 39: Testis - Nuclear processes | Tissue enriched | Detected in all | 5 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 6 | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Liver Hepatocellular Carcinoma",
"Prostate Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Prostate Adenocarcinoma"
] | 15,337 | 6 |
ENSG00000185800 | DMWD | DM1 locus, WD repeat containing | [
"Q09019"
] | 19 | 45782947-45792845 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA068172",
"HPA069843"
] | [
"D19S593E",
"DMR-N9",
"gene59"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane",
"Actin filaments"
] | [] | [] | [] | Approved | Approved | null | 8 | null | null | Cluster 24: Non-specific - Transcription | Cluster 51: Neurons - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 15,338 | 1 |
ENSG00000185803 | SLC52A2 | Solute carrier family 52 member 2 | [
"Q9HAB3"
] | 8 | 144333957-144361286 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA063036"
] | [
"D15Ertd747e",
"FLJ11856",
"GPCR41",
"GPR172A",
"hRFT3",
"PAR1",
"RFVT2"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [
"Host cell receptor for virus entry",
"Receptor"
] | [
"Deafness",
"Disease variant",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Approved | null | 4 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 40: Non-specific - Unknown function | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 15,339 | 8 |
ENSG00000185808 | PIGP | Phosphatidylinositol glycan anchor biosynthesis class P | [
"P57054"
] | 21 | 37062846-37073170 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA026921"
] | [
"DCRC",
"DSCR5",
"DSRC"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"GPI-anchor biosynthesis"
] | [] | [
"Disease variant",
"Epilepsy"
] | [
"Vesicles"
] | [] | [] | [] | Approved | Uncertain | null | 21 | Yes | No | Cluster 30: Non-specific - DNA binding | Cluster 30: White matter - Myelination | Cluster 47: Leukemia - Hemostasis | Cluster 3: Early primary spermatocytes - Early meiosis | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 15,340 | 3 |
ENSG00000185811 | IKZF1 | IKAROS family zinc finger 1 | [
"Q13422"
] | 7 | 50304068-50405101 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009247",
"HPA035221",
"HPA035222"
] | [
"hIk-1",
"Hs.54452",
"IKAROS",
"LyF-1",
"PPP1R92",
"ZNFN1A1"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transcription factors"
] | [
"Cell cycle",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Chromatin regulator",
"Developmental protein",
"DNA-binding",
"Repressor"
] | [
"Cancer-related genes",
"Disease variant"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 92 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 20: Macrophages & Microglia - Immune response | Cluster 55: Lymphoma - Immune response | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 44: Bone marrow - Nuclear processes | Group enriched | Detected in many | 8 | Group enriched | Detected in some | 104 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma"
] | 15,341 | 7 |
ENSG00000185813 | PCYT2 | Phosphate cytidylyltransferase 2, ethanolamine | [
"Q99447"
] | 17 | 81900958-81911432 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA023033",
"HPA023034"
] | [
"ET"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Phospholipid biosynthesis",
"Phospholipid metabolism"
] | [
"Nucleotidyltransferase",
"Transferase"
] | [
"Disease variant",
"Hereditary spastic paraplegia",
"Neurodegeneration"
] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | 8 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 49: Hindbrain - Mixed function | Cluster 18: Liver cancer - Metabolism | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 67: Testis - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 6 | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 15,342 | 3 |
ENSG00000185818 | NAT8L | N-acetyltransferase 8 like | [
"Q8N9F0"
] | 4 | 2059327-2069089 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA040677"
] | [
"FLJ37478",
"Hcml3",
"Shati"
] | [
"Disease related genes",
"Enzymes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins"
] | [] | [
"Acyltransferase",
"Transferase"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | null | null | 2 | null | null | Cluster 44: Plasmacytoid DCs - Plasma membrane proteins | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 91: Pituicytes/FSC - Homeostasis & neuron support | Cluster 10: Brain - Synaptic signal transduction | Group enriched | Detected in many | 4 | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,343 | 4 |
ENSG00000185821 | OR6C76 | Olfactory receptor family 6 subfamily C member 76 | [
"A6NM76"
] | 12 | 55426254-55427192 | No human protein/transcript evidence | No human protein/transcript evidence | No human protein/transcript evidence | No human protein/transcript evidence | [] | [] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Olfaction",
"Sensory transduction"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | null | null | null | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,344 | 9 |
ENSG00000185823 | NPAP1 | Nuclear pore associated protein 1 | [
"Q9NZP6"
] | 15 | 24675775-24683393 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018828",
"HPA019562"
] | [
"C15orf2"
] | [
"Human disease related genes",
"Predicted intracellular proteins",
"Transporters"
] | [
"Differentiation",
"Spermatogenesis"
] | [
"Developmental protein"
] | [] | [
"Nucleoplasm"
] | [
"Vesicles",
"Plasma membrane"
] | [] | [] | Supported | Uncertain | null | null | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | null | Cluster 64: Renal epithelial cells - Ion transport & homeostasis | Cluster 67: Testis - Mixed function | Tissue enhanced | Detected in single | null | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,345 | 3 |
ENSG00000185825 | BCAP31 | B cell receptor associated protein 31 | [
"P51572"
] | X | 153700492-153724565 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003906",
"CAB015350",
"CAB015424"
] | [
"6C6-Ag",
"BAP31",
"CDM",
"DXS1357E"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Apoptosis",
"ER-Golgi transport",
"Host-virus interaction",
"Protein transport",
"Transport"
] | [] | [
"Deafness",
"Dystonia",
"Intellectual disability"
] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Enhanced | Supported | Approved | 139 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 45: Non-specific - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 15,346 | 7 |
ENSG00000185829 | ARL17A | ADP ribosylation factor like GTPase 17A | [
"Q8IVW1"
] | 17 | 46499780-46579695 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA046814",
"HPA047080"
] | [
"ARF1P2",
"ARL17P1"
] | [
"Predicted intracellular proteins"
] | [
"ER-Golgi transport",
"Protein transport",
"Transport"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Uncertain | null | null | null | null | Cluster 32: Basophils - Transcription | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 27: Breast cancer - Unknown function | Cluster 102: Non-specific - Mixed function | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Rectum Adenocarcinoma"
] | [] | [
"Rectum Adenocarcinoma"
] | 15,347 | 6 |
ENSG00000185838 | GNB1L | G protein subunit beta 1 like | [
"Q9BYB4"
] | 22 | 19783223-19854939 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA034627",
"HPA034628"
] | [
"GY2",
"WDR14"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"DNA damage"
] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 34: Non-specific - Mixed function | Cluster 66: Non-specific - Mitochondria | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 15,348 | 9 |
ENSG00000185842 | DNAH14 | Dynein axonemal heavy chain 14 | [
"Q0VDD8"
] | 1 | 224896262-225399292 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA027718",
"HPA028545",
"HPA031379"
] | [
"C1orf67",
"DKFZp781B1548",
"Dnahc14",
"HL-18",
"HL18",
"MGC27277"
] | [
"Predicted intracellular proteins"
] | [] | [
"Motor protein"
] | [] | [
"Centrosome",
"Basal body"
] | [
"Golgi apparatus"
] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 24: Non-specific - Transcription | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 71: Lymphoma - Inflammatory response | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 21: Testis - Mixed function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 15,349 | 3 |
ENSG00000185860 | CCDC190 | Coiled-coil domain containing 190 | [
"Q86UF4"
] | 1 | 162824458-162868761 | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | [
"HPA028579",
"HPA028584",
"HPA028592"
] | [
"C1orf110",
"MGC48998"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Actin filaments",
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 46: Brainstem - Mixed function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 11: Esophagus - Basic cellular processes | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in some | 10 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,350 | 6 |
ENSG00000185862 | EVI2B | Ecotropic viral integration site 2B | [
"P34910"
] | 17 | 31303770-31314105 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA007346",
"HPA053383"
] | [
"CD361",
"D17S376",
"EVDB"
] | [
"CD markers",
"Predicted membrane proteins"
] | [] | [] | [
"Proto-oncogene"
] | [
"Plasma membrane"
] | [] | [] | [] | Approved | Enhanced | null | null | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 30: White matter - Myelination | Cluster 51: Myeloma - Immunoglobulins | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in all | null | Group enriched | Detected in many | 11 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 15,351 | 3 |
ENSG00000185863 | TMEM210 | Transmembrane protein 210 | [
"A6NLX4"
] | 9 | 137170858-137172056 | Evidence at protein level | Evidence at protein level | No human protein/transcript evidence | Evidence at protein level | [
"HPA066907"
] | [] | [
"Predicted membrane proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | null | null | null | Cluster 44: Plasmacytoid DCs - Plasma membrane proteins | null | Cluster 60: Prostate cancer - Unknown function | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 79: Testis - Spermatogenesis | Tissue enriched | Detected in some | 23 | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in single | null | Group enriched | Detected in some | 7 | Immune cell enriched | Detected in single | 33 | 0 | 0 | 0 | [] | [] | [] | 15,352 | 4 |
ENSG00000185864 | NPIPB4 | Nuclear pore complex interacting protein family member B4 | [
"C9JG80"
] | 16 | 21834569-21880827 | Evidence at protein level | Evidence at protein level | No human protein/transcript evidence | Evidence at transcript level | [
"HPA053611"
] | [] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | null | null | null | Cluster 32: Basophils - Transcription | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 56: Non-specific - Sensory perception | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 15,353 | 1 |
ENSG00000185869 | ZNF829 | Zinc finger protein 829 | [
"Q3KNS6"
] | 19 | 36888124-36916291 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA073073"
] | [
"DKFZp779O175"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Nuclear bodies"
] | [] | [] | Approved | null | null | 6 | No | No | Cluster 5: Non-specific - Cell proliferation | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 4: Non-specific - Transcription | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 57: Testis - Spermatogenesis | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in many | 4 | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 15,354 | 2 |
ENSG00000185873 | TMPRSS11B | Transmembrane serine protease 11B | [
"Q86T26"
] | 4 | 68226653-68245694 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [] | [
"HATL5"
] | [
"Enzymes",
"Predicted membrane proteins"
] | [] | [
"Hydrolase",
"Protease",
"Serine protease"
] | [] | [] | [] | [] | [] | null | null | null | 78 | null | null | null | Cluster 30: White matter - Myelination | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 84: Apical squamous epithelium - Cornification | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Group enriched | Detected in some | 6 | Cell type enriched | Detected in some | 52 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,355 | 4 |
ENSG00000185875 | THNSL1 | Threonine synthase like 1 | [
"Q8IYQ7"
] | 10 | 25016612-25026664 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA037585"
] | [
"FLJ22002",
"TSH1"
] | [
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nuclear bodies",
"Cytosol"
] | [
"Mitochondria"
] | [] | [] | Approved | Uncertain | null | 7 | null | null | Cluster 24: Non-specific - Transcription | Cluster 14: Neurons - Synaptic function | Cluster 52: Non-specific - Mitochondria | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 16: Liver & Kidney - Metabolism | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,356 | 1 |
ENSG00000185883 | ATP6V0C | ATPase H+ transporting V0 subunit c | [
"P27449"
] | 16 | 2513952-2520218 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA065100"
] | [
"ATP6C",
"ATP6L",
"ATPL",
"VATL",
"Vma3"
] | [
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Host-virus interaction",
"Hydrogen ion transport",
"Ion transport",
"Transport"
] | [] | [
"Disease variant",
"Epilepsy"
] | [
"Vesicles"
] | [] | [] | [] | Approved | null | null | 117 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 54: Non-specific - Transcription | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 15,358 | 5 |
ENSG00000185885 | IFITM1 | Interferon induced transmembrane protein 1 | [
"P13164"
] | 11 | 310041-315272 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004810",
"CAB017615"
] | [
"9-27",
"CD225",
"DSPA2a",
"IFI17"
] | [
"CD markers",
"Plasma proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Antiviral defense",
"Immunity",
"Innate immunity",
"Osteogenesis"
] | [] | [] | [
"Golgi apparatus",
"Plasma membrane"
] | [] | [] | [] | Approved | Enhanced | null | 36 | null | null | Cluster 24: Non-specific - Transcription | Cluster 47: Endothelial cells - Vasculature | Cluster 31: Non-specific - Antiviral immune response | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in all | 5 | 1 | 0 | 1 | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 15,359 | 6 |
ENSG00000185888 | PRSS38 | Serine protease 38 | [
"A1L453"
] | 1 | 227815675-227846470 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [] | [
"MPN2"
] | [
"Enzymes",
"Predicted secreted proteins"
] | [] | [
"Hydrolase",
"Protease",
"Serine protease"
] | [] | [] | [] | [
"Secreted in male reproductive system"
] | [
"Enzyme"
] | null | null | null | null | null | null | null | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 3: Early primary spermatocytes - Early meiosis | Cluster 79: Testis - Spermatogenesis | Tissue enriched | Detected in single | 42 | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,360 | 5 |
ENSG00000185894 | BPY2C | Basic charge Y-linked 2C | [
"O14599"
] | Y | 25030901-25062548 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"VCY2C"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | 1 | null | null | null | null | null | null | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in single | 6 | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,361 | 6 |
ENSG00000185896 | LAMP1 | Lysosomal associated membrane protein 1 | [
"P11279"
] | 13 | 113297239-113323672 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004260",
"HPA014750"
] | [
"CD107a"
] | [
"CD markers",
"Plasma proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Host-virus interaction"
] | [
"Host cell receptor for virus entry",
"Receptor"
] | [] | [] | [] | [] | [] | null | Supported | null | 250 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 30: White matter - Myelination | Cluster 19: Non-specific - Unknown function | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 15,362 | 2 |
ENSG00000185897 | FFAR3 | Free fatty acid receptor 3 | [
"O14843"
] | 19 | 35358460-35360489 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA044681"
] | [
"FFA3R",
"GPR41"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Immunity",
"Inflammatory response"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 12 | null | null | Cluster 28: Neutrophils - Unknown function | Cluster 11: White matter - Signal transduction | Cluster 50: Lymphoma - Unknown function | Cluster 58: Mast cells - Allergic inflammatory responses | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 5 | 0 | 0 | 0 | [] | [] | [] | 15,363 | 1 |
ENSG00000185899 | TAS2R60 | Taste 2 receptor member 60 | [
"P59551"
] | 7 | 143443453-143444409 | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | Evidence at transcript level | [
"HPA030416"
] | [
"T2R60"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Sensory transduction",
"Taste"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | null | Cluster 24: Non-specific - Unknown function | null | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,364 | 4 |
ENSG00000185900 | POMK | Protein O-mannose kinase | [
"Q9H5K3"
] | 8 | 43093498-43131180 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA013321"
] | [
"FLJ23356",
"SgK196"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Kinase",
"Transferase"
] | [
"Congenital muscular dystrophy",
"Disease variant",
"Dystroglycanopathy",
"Limb-girdle muscular dystrophy",
"Lissencephaly"
] | [] | [] | [] | [] | null | Uncertain | null | 62 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 14: Neurons - Synaptic function | Cluster 30: Non-specific - Gene expression regulation | Cluster 82: Dendritic cells - Antigen presentation | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 4 | 0 | 4 | [
"Glioblastoma Multiforme",
"Lung Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 15,365 | 4 |
ENSG00000185905 | C16orf54 | Chromosome 16 open reading frame 54 | [
"Q6UWD8"
] | 16 | 29742463-29745990 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA060546"
] | [
"FLJ35681"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 8 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 6: Non-specific - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Group enriched | Detected in many | 5 | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Skin Cutaneous Melanoma"
] | [] | [
"Skin Cutaneous Melanoma"
] | 15,366 | 6 |
ENSG00000185909 | KLHDC8B | Kelch domain containing 8B | [
"Q8IXV7"
] | 3 | 49171598-49176486 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA008463",
"HPA014467"
] | [
"MGC35097"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division"
] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Enhanced | Approved | null | 3 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 47: Leukemia - Hemostasis | Cluster 47: Platelets - Hemostasis | Cluster 4: Adrenal gland - Steroid metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 4 | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 15,367 | 5 |
ENSG00000185915 | KLHL34 | Kelch like family member 34 | [
"Q8N239"
] | X | 21654690-21658330 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA060287"
] | [
"FLJ34960",
"RP11-450P7.3"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 32 | null | null | Cluster 39: T-cells - T-cell receptor | Cluster 51: Neurons - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 19: Skeletal muscle - Striated muscle contraction | Tissue enriched | Detected in some | 8 | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 15,368 | 5 |
ENSG00000185917 | SETD4 | SET domain containing 4 | [
"Q9NVD3"
] | 21 | 36034541-36079389 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024073",
"HPA035405"
] | [
"C21orf18",
"C21orf27"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"Inflammatory response"
] | [
"Methyltransferase",
"Transferase"
] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Approved | Approved | null | null | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 31: Non-specific - Transcription | Cluster 47: Leukemia - Hemostasis | Cluster 7: Non-specific - Transcription | Cluster 56: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Ovary Serous Cystadenocarcinoma"
] | 15,369 | 8 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.